https://cmet-signaling.com/ind....ex.php/mitochondria-
Between 30 and 50% of patients with major depressive disorder (MDD) do not react sufficiently to antidepressant regimens. The standard pharmacological treatments predominantly target serotonergic brain signaling but better resources to predict therapy reaction and identify relevant subgroups of MDD are needed to support individualized and mechanistically targeted treatment strategies. The aim of this study is to explore antidepre
Like
Comment
Share
